Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
Satapathy
Sanjay K
SK
Departments of Gastroenterology and Pathology, GB Pant Hospital, New Delhi 110-002, India.
Garg
Sanjay
S
Chauhan
Ranjeet
R
Sakhuja
Puja
P
Malhotra
Veena
V
Sharma
Barjesh C
BC
Sarin
Shiv K
SK
D000328:Adult; D005234:Fatty Liver / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000627:therapeutic use*; D010865:Pilot Projects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline